tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market
Advertisement

Ascendis Pharma (ASND) Technical Analysis

Compare
649 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Ascendis Pharma’s (ASND) Moving Averages Convergence Divergence (MACD) indicator is 3.30, suggesting Ascendis Pharma is a Sell.
Ascendis Pharma’s (ASND) 20-Day exponential moving average is 199.63, while Ascendis Pharma’s (ASND) share price is $209.86, making it a Buy.
Ascendis Pharma’s (ASND) 50-Day exponential moving average is 193.32, while Ascendis Pharma’s (ASND) share price is $209.86, making it a Buy.

Ascendis Pharma (ASND) Pivot Points

Oct 08, 2025, 05:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
190.23
195.90
203.37
209.04
216.50
222.17
229.64
Fibonacci
195.90
200.92
204.02
209.04
214.06
217.16
222.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND) Moving Averages

Oct 08, 2025, 05:19 PM
Period
Simple
Exponential
MA5
205.96Buy
205.95Buy
MA10
199.52Buy
202.48Buy
MA20
198.29Buy
199.63Buy
MA50
194.01Buy
193.32Buy
MA100
182.04Buy
183.52Buy
MA200
164.38Buy
166.56Buy
Ascendis Pharma’s (ASND) 10-Day exponential moving average is 202.48, while Ascendis Pharma’s (ASND) share price is $209.86, making it a Buy.
Ascendis Pharma’s (ASND) 100-Day exponential moving average is 183.52, while Ascendis Pharma’s (ASND) share price is $209.86, making it a Buy.
Ascendis Pharma’s (ASND) stock price is $209.86 and Ascendis Pharma’s (ASND) 50-day simple moving average is 194.01, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $209.86 and Ascendis Pharma’s (ASND) 100-day simple moving average is 182.04, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $209.86 and Ascendis Pharma’s (ASND) 200-day simple moving average is 164.38, creating a Buy signal.

Ascendis Pharma (ASND) Technical Indicators

Oct 08, 2025, 05:19 PM
Name
Value
Implied Action
RSI (14)
65.42
Neutral
STOCH (9,6)
86.79
Sell
STOCHRSI (14)
86.79
Sell
MACD (12,26)
3.30
Sell
ADX (14)
22.71
Neutral
Williams %R
-17.66
Sell
CCI (14)
190.00
Sell
ATR (14)
6.47
-
Ultimate Oscillator
63.75
Neutral
ROC
5.15
Buy
Ascendis Pharma’s (ASND) Relative Strength Index (RSI) is 65.42, creating a Neutral signal.
Ascendis Pharma’s (ASND) Trend Strength Indicator (ADX) is 22.71, creating a Neutral signal.
Ascendis Pharma’s (ASND) Commodity Channel Index (CCI) is 190.00, creating a Sell signal.
Ascendis Pharma’s (ASND) Price Rate of Change (ROC) is 5.15, creating a Buy signal.

FAQ

Is ASND a Buy, Hold, or Sell?
Based on ASND’s technical indicators, ASND is a Buy.
    What is ASND’s RSI (14)?
    ASND’s RSI (14) is 65.42, which suggests ASND is a Neutral.
      What is ASND’s MACD?
      ASND’s MACD is 3.30, which suggests ASND is a Sell.
        What is ASND’s 5-day moving average?
        ASND’s 5-day moving average is 205.96, which suggests ASND is a Buy.
          What is ASND’s 20-day moving average?
          ASND 20-day moving average is 198.29, which suggests ASND is a Buy.
            What is ASND’s 50-day moving average?
            ASND’s 50-day moving average is 194.01, which suggests ASND is a Buy.
              What is ASND’s 200-day moving average?
              ASND’s 200-day moving average is 164.38, which suggests ASND is a Buy.
                What is ASND’s Williams % R (14)?
                ASND’s Williams % R (14) is -17.66, which suggests ASND is a Sell.
                  What is ASND’s CCI (14)?
                  ASND’s CCI (14) is 190.00, which suggests ASND is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis